Bordetella parapertussis evolved in a host population that had already developed immunity to "B. pertussis", where being able to evade "B. pertussis" immunity was an advantage. Two lineages of "B. parapertussis" have been described. The first infects humans and is responsible for a minority of cases of the disease pertussis (also known as whooping cough). The second, ovine, lineage causes chronic nonprogressive pneumonia in sheep. Both lineages are thought to have evolved from a "B. bronchiseptica"-like ancestor. This disease can be symptomatic or asymptomatic and may predispose hosts to secondary infection. Bordetella parapertussis Bordetella parapertussis is a small Gram-negative bacterium of the
Schindler disease of the disease is mostly palliative. However, Type II Schindler disease, with its late onset of symptoms, is not characterized by neurological degeneration. There is no known cure for Schindler disease, but bone marrow transplants have been trialed, as they have been successful in curing other glycoprotein disorders. Schindler disease was named after Detlev Schindler (1946- ) M.D., the first author of a 1988 paper detailing the disease. It also named after the Japanese Biochemist and Physician, Hiro Kanzaki (1949- ), who further studied it and released papers detailing the disease in 2006. Schindler disease Schindler disease, also known as